Document is current
Any future updates will be listed below
-
Authors
Coca-Pelaz, Andrés https://orcid.org/0000-0003-1363-8559
Rodrigo, Juan P.
Agaimy, Abbas
Williams, Michelle D.
Saba, Nabil F.
Nuyts, Sandra
Randolph, Gregory W.
López, Fernando
Vander Poorten, Vincent
Kowalski, Luiz P.
Civantos, Francisco J.
Zafereo, Mark E.
Mäkitie, Antti A.
Cohen, Oded
Nixon, Iain J.
Rinaldo, Alessandra https://orcid.org/0000-0001-7956-6709
Ferlito, Alfio https://orcid.org/0000-0002-8247-8002
- License Information
-
More Information
Article History
Received: 20 December 2023
Revised: 23 January 2024
Accepted: 28 January 2024
First Online: 24 February 2024
Declarations
:
: Mark E. Zafereo reports grant funding from Eli Lilly and Merck to MD Anderson Cancer Center for clinical trials. Other authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
